主动监测中多次阴性前列腺活检的临床意义:癌症消失还是隐藏?
这项前瞻性队列研究纳入514例低危前列腺癌主动监测患者,分析连续阴性活检的长期意义。结果显示,1次或连续2次阴性活检与后续活检阴性及更低积极治疗风险独立相关,且连续阴性者10年无治疗生存率最高(84%)。
要点
- 连续阴性活检与 favorable 临床风险因素相关
- 阴性活检次数越多,后续活检检出癌风险越低
- 连续阴性活检者10年无治疗生存率最高
核心结论
- 连续阴性监测活检与有利的临床风险因素相关,并独立关联后续阴性活检和较低积极治疗风险。
研究设计与样本
- 前瞻性主动监测数据库队列研究,纳入至少4次活检的低危前列腺癌男性,共514例。
主要发现
- 514例中112例(22%)有1次阴性活检,78例(15%)有连续2次阴性活检。
- 1次阴性活检者中位PSA密度0.11,连续阴性者0.10,从未阴性者0.13(p<0.01)。
- 单变量分析:较高PSA密度(OR 1.68,95%CI 1.16-2.45)和可疑MRI病灶(OR 2.00,95%CI 1.16-3.42)与第4次活检检出癌风险升高相关。
- 多变量分析:1次阴性活检(OR 0.22,95%CI 0.12-0.41)和连续阴性活检(OR 0.12,95%CI 0.06-0.24)与结局活检检出癌风险降低相关。
- 未调整10年无治疗生存率:连续阴性者84%,1次阴性者74%,从未阴性者66%(log rank p=0.02)。
临床怎么用
- 连续阴性监测活检可增强对低风险前列腺癌惰性病程的信心,支持继续主动监测。
- PSA密度较高或MRI可疑病灶者,即使有阴性活检史,仍需警惕后续活检检出癌可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Men with low risk prostate cancer on active surveillance undergo multiple biopsies over time. The long-term clinical significance of consecutively negative biopsies is not known. MATERIALS AND METHODS: Men with low risk prostate cancer prospectively enrolled in an active surveillance database with at least 4 biopsies were included in the study. Exposure variables were 0, 1 or 2 consecutively negative biopsies after diagnosis. Other variables included age, prostate specific antigen, prostate specific antigen density, Gleason grade group, percent positive cores and magnetic resonance imaging findings. Outcome variables were the detection of any cancer at fourth biopsy and active treatment. RESULTS: A total of 514 men were included, with 112 (22%) men having 1 negative biopsy and 78 (15%) with 2 consecutively negative biopsies. Median prostate specific antigen density was lower for men with 1 negative biopsy (0.11) and consecutively negative biopsies (0.10) compared to men who never had a negative biopsy (0.13, p <0.01). On univariable logistic regression higher prostate specific antigen density (OR 1.68, 95% CI 1.16-2.45) and suspicious magnetic resonance imaging lesions (OR 2.00, 95% CI 1.16-3.42) were associated with a higher likelihood of detecting cancer on fourth biopsy. On multivariable logistic regression 1 negative biopsy (OR 0.22, 95% CI 0.12-0.41) and consecutively negative biopsies (OR 0.12, 95% CI 0.06-0.24) were associated with a lower likelihood of detecting cancer at outcome biopsy. Unadjusted 10-year treatment-free survival was highest for patients with consecutively negative biopsies (84%) and 1 negative biopsy (74%) than those who had none (66%) (log rank p=0.02). CONCLUSIONS: Consecutively negative surveillance biopsies are correlated with favorable clinical risk factors and independently associated with subsequent negative biopsy and lower risk of active treatment.
引用
- Chu CE, Cowan JE, Fasulo V, et al. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide? J Urol. 2020. PMID: 33198555. doi:10.1097/JU.0000000000001339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。